Bates Kelly R, Zaza Norah N, Vitello Dominic J, Bentrem Hannah, Stryker Steven J, Keswani Rajesh N, Logan Charles D
Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Department of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
J Surg Oncol. 2025 Jul;132(1):146-154. doi: 10.1002/jso.28160. Epub 2025 May 20.
Digital rectal exam (DRE) is an important screening tool for early cancer identification. DRE has become less routinely performed following removal from cancer screening guidelines. The effect of this decreased utilization has not been studied; this study sought to evaluate current DRE utilization and changes over time.
The electronic medical record database of a regional academic health system was assessed between 2015 and 2020 for encounters with patients aged 45-75. DRE rates and yearly trends were assessed using chi-squared and Cochran-Armitage tests, respectively.
Of 191 329 outpatient encounters, DRE was documented on 8.5% of visits. DRE utilization declined from 2015 to 2020 (9.6% vs. 8.9%). DRE was more often identified as a procedure in surgical specialties, including surgical oncology (55.6%) and general surgery (2.8%), compared to primary care specialties, including family medicine (1.7%) and internal medicine (1.6%). DREs were less frequently documented for non-Hispanic Black patients versus non-Black patients (7.2% vs. 8.4%) and for Hispanic patients versus Non-Hispanic White patients (7.6% vs. 8.5%). Men had a documented DRE procedure more frequently than women overall (10.4% vs. 4.6%) and in encounters with primary care specialties (2.3% vs. 0.5%) and surgical specialties (20.4% vs. 13.5%) (all p < 0.001).
In this contemporary evaluation, DRE was less frequently coded during outpatient clinic visits overall and specifically in primary care compared with surgical specialties. Differences in DRE utilization across sociodemographic factors highlight disparities in cancer screening. Low DRE rates represent a missed opportunity for early identification of high prevalence cancers.
直肠指检(DRE)是早期癌症识别的重要筛查工具。自直肠指检从癌症筛查指南中移除后,其常规执行频率降低。这种利用率下降的影响尚未得到研究;本研究旨在评估当前直肠指检的利用率及其随时间的变化。
对一个地区学术健康系统2015年至2020年间45 - 75岁患者的电子病历数据库进行评估。分别使用卡方检验和 Cochr an - Armitage检验评估直肠指检率及年度趋势。
在191329次门诊就诊中,有8.5%的就诊记录了直肠指检。直肠指检的利用率从2015年到2020年有所下降(9.6%对8.9%)。与初级保健专科(包括家庭医学,1.7%;内科,1.6%)相比,直肠指检在外科专科(包括外科肿瘤学,55.6%;普通外科,2.8%)中更常被列为一项检查。非西班牙裔黑人患者的直肠指检记录频率低于非黑人患者(7.2%对8.4%),西班牙裔患者低于非西班牙裔白人患者(7.6%对8.5%)。总体而言,男性的直肠指检记录频率高于女性(10.4%对4.6%),在初级保健专科就诊中(2.3%对0.5%)以及外科专科就诊中(20.4%对13.5%)均如此(所有p < 0.001)。
在本次当代评估中,与外科专科相比,直肠指检总体上在门诊就诊期间尤其是在初级保健中编码频率较低。直肠指检利用率在社会人口统计学因素方面的差异凸显了癌症筛查中的差异。低直肠指检率代表了早期识别高发性癌症的机会错失。